Novavax 96.4% effective against original variant of COVID
Health
- 12 March, 2021
- 06:26
The Novavax coronavirus vaccine proved 96.4 percent effective against the original variant of coronavirus and 86.3 percent effective against its British strain, Report informs, referring to RIA Novosti.
The third phase of the NVX CoV2373 vaccine trial took place in the UK. The study covered more than 15,000 participants aged 18-84, 27 percent of them were over 65.
The company also said that when it comes to severe form of COVID, the vaccine has demonstrated 100 percent effectiveness.
Latest News
17:53
Likhachev: Shell hit protective perimeter of Iran's Bushehr nuclear plant
Region17:39
Trump calls NATO 'extremely unreliable partner,' labels himself 'favorite President'
Other countries17:32
Iran strikes Israel's Ben-Gurion Airport in drone attack
Other countries17:26
Azerbaijan to launch mobile app for tax declarations
Business17:22
Iran launches over 280 attacks on Jordan since Middle East escalation began
Other countries17:07
Credit investments in Azerbaijan's economy rise nearly 9% in a year
Finance16:58
IRGC claims strikes on US sites in Kuwait and Bahrain
Other countries16:44
Orban warns of looming energy crisis in Europe
Other countries16:37